Ragni E, Lassale B
Responsable Médical Direction Qualité, Vigilances, Gestion des Risques et Relation avec les Usagers AP-HM, 80, rue Brochier, 13005 Marseille, France.
Correspondant d'Hémovigilance et de sécurité transfusionnelle, coordonnateur des vigilances AP-HM, 270, boulevard Sainte-Marguerite, 13274 Marseille cedex 9, France.
Transfus Clin Biol. 2021 Nov;28(4):349-352. doi: 10.1016/j.tracli.2021.09.006. Epub 2021 Sep 14.
The HAS certification for healthcare organisation has gradually introduced the concepts of risk and relevance of care. Related to quality and safety of care, the transfusion act has early been part of the referential, and it seemed interesting to us to observe the changes in the requirements on this topic. After taking into account the regulations and the organization of haemovigilance in the establishment, it is now the search for the factual result for the patient which is the objective of the two main criteria devoted to transfusion. At the same time as the referential, the investigation methods have also evolved: the targeted tracer for Labile Blood Products and Blood-Derived Medicines allows a more detailed analysis geared towards the effective implementation of good transfusion practices. In conclusion, certification has moved from organizing and auditing the process to directly measuring transfusion safety for the patient.
医疗机构的HAS认证已逐步引入护理风险和相关性的概念。与护理质量和安全相关，输血法案很早就成为了参考标准的一部分，对我们来说，观察该主题要求的变化似乎很有趣。在考虑了机构内的法规和血液警戒组织后，现在致力于输血的两个主要标准的目标是为患者寻求实际结果。与参考标准同时，调查方法也有所发展：针对不稳定血液制品和血液衍生药物的靶向追踪器有助于进行更详细的分析，以有效实施良好的输血实践。总之，认证已从对过程的组织和审核转向直接衡量患者的输血安全性。
